CCA
BSX icon

Checchi Capital Advisers’s Boston Scientific BSX Stock Holding History

Checchi Capital Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Sell
9,390
-1,768
-16% -$96K 0.02% 407
2026
Q1 		$700K Buy
11,158
+1,032
+10% +$82.6K 0.04% 275
2025
Q4 		$965K Sell
10,126
-380
-4% -$37.3K 0.05% 206
2025
Q3 		$1.03M Sell
10,506
-1,045
-9% -$108K 0.05% 198
2025
Q2 		$1.24M Sell
11,551
-178
-2% -$18K 0.07% 186
2025
Q1 		$1.18M Buy
11,729
+123
+1% +$12.4K 0.06% 192
2024
Q4 		$1.04M Buy
11,606
+71
+0.6% +$6.25K 0.06% 192
2024
Q3 		$967K Sell
11,535
-103
-0.9% -$8.12K 0.05% 205
2024
Q2 		$896K Buy
11,638
+170
+1% +$12.4K 0.04% 207
2024
Q1 		$785K Buy
11,468
+78
+0.7% +$5.01K 0.06% 229
2023
Q4 		$658K Buy
11,390
+740
+7% +$39.5K 0.05% 246
2023
Q3 		$562K Sell
10,650
-335
-3% -$17.6K 0.05% 259
2023
Q2 		$594K Buy
10,985
+74
+0.7% +$3.87K 0.05% 257
2023
Q1 		$546K Buy
10,911
+860
+9% +$40.5K 0.05% 268
2022
Q4 		$465K Sell
10,051
-351
-3% -$15.2K 0.05% 289
2022
Q3 		$403K Buy
10,402
+52
+0.5% +$2.09K 0.04% 314
2022
Q2 		$425K Sell
10,350
-542
-5% -$22.1K 0.04% 325
2022
Q1 		$482K Buy
10,892
+785
+8% +$34K 0.04% 269
2021
Q4 		$429K Sell
10,107
-96
-0.9% -$4.03K 0.04% 295
2021
Q3 		$443K Buy
10,203
+263
+3% +$11.6K 0.04% 273
2021
Q2 		$425K Sell
9,940
-199
-2% -$8.37K 0.04% 281
2021
Q1 		$392K Sell
10,139
-493
-5% -$18.7K 0.04% 280
2020
Q4 		$382K Sell
10,632
-2,033
-16% -$73.3K 0.04% 283
2020
Q3 		$484K Buy
12,665
+449
+4% +$17.3K 0.05% 208
2020
Q2 		$429K Buy
12,216
+1,476
+14% +$53.2K 0.05% 227
2020
Q1 		$350K Sell
10,740
-1,320
-11% -$51.6K 0.03% 225
2019
Q4 		$545K Sell
12,060
-468
-4% -$19.6K 0.07% 193
2019
Q3 		$510K Buy
12,528
+181
+1% +$7.67K 0.07% 192
2019
Q2 		$531K Buy
12,347
+1,199
+11% +$46.1K 0.07% 182
2019
Q1 		$428K Sell
11,148
-801
-7% -$30.6K 0.05% 208
2018
Q4 		$422K Sell
11,949
-1,892
-14% -$68.6K 0.05% 192
2018
Q3 		$533K Buy
13,841
+118
+0.9% +$4.12K 0.06% 201
2018
Q2 		$449K Buy
13,723
+161
+1% +$4.86K 0.06% 219
2018
Q1 		$371K Buy
13,562
+197
+1% +$5.35K 0.05% 247
2017
Q4 		$331K Buy
13,365
+1,704
+15% +$47K 0.04% 283
2017
Q3 		$340K Sell
11,661
-420
-3% -$11.6K 0.03% 247
2017
Q2 		$335K Sell
12,081
-1,472
-11% -$39.1K 0.04% 252
2017
Q1 		$337K Buy
13,553
+349
+3% +$8.49K 0.04% 251
2016
Q4 		$286K Sell
13,204
-242
-2% -$5.28K 0.04% 281
2016
Q3 		$320K Buy
13,446
+2,502
+23% +$59.7K 0.04% 239
2016
Q2 		$256K Buy
10,944
+358
+3% +$7.75K 0.03% 275
2016
Q1 		$199K Sell
10,586
-398
-4% -$6.99K 0.04% 346
2015
Q4 		$203K Buy
+10,984
New +$197K 0.05% 324

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Checchi Capital Advisers's BSX Position: Q2 2026 in Review

Checchi Capital Advisers reduced its Boston Scientific (BSX) stake by 16% in Q2 2026, selling an estimated $96K and leaving 9,390 shares worth $401K. The position accounts for 0.02% of the portfolio, ranked #407.

Checchi Capital Advisers first reported a position in BSX in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.24M in Q2 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Checchi Capital Advisers held 9,390 shares of Boston Scientific worth $401K as of Q2 2026.
  • Checchi Capital Advisers sold 1,768 Boston Scientific shares in Q2 2026, an estimated $96K.
  • Boston Scientific made up 0.02% of Checchi Capital Advisers's portfolio in Q2 2026, its #407 holding.
  • Checchi Capital Advisers first reported a position in Boston Scientific in Q4 2015 and has held it in 43 quarters since.
  • Checchi Capital Advisers's Boston Scientific position peaked at $1.24M in Q2 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.